Searched for
ASTRAZENECA PHARMA EARNINGS
Trending stocks: AstraZeneca Pharma shares gain over 1%A total of 1,321 shares changed hands on the counter till 11:40AM (IST).06 Jul, 2020, 11.44 AM IST- Street votes for companies with no debt overhang to outlast tough timesShares of 47 of 60 debt-free companies in BSE 500 index have gained as much as 100% in '19.09 Jan, 2020, 08.00 AM IST
- AstraZeneca Pharma Q4 profit jumps threefold to Rs 10 croreTotal income stood at Rs 196.31 crore in the quarter, compared with Rs 153.06 crore a year ago.24 May, 2019, 07.47 PM IST
- Below the radar thus far, pharma picking up pace, slowly but surelyHaving been battered on D-Street for quite a long time now, this segment is finally showing hope.21 Feb, 2019, 11.08 AM IST
- Invest 15-20% of your portfolio in select pharma stocks; MNCs can be better betsClinton is generally perceived to be negative for pharma companies on the premise that she would try to curb the profits earned by the drug...09 Nov, 2016, 01.10 AM IST
- Dr Reddy’s pain may bring gains for Torrent & CiplaThe drug in focus is the generic version of Nexium, a heartburn pill, which has earned over $5.5 billion for the owner AstraZeneca so far.02 Dec, 2015, 02.05 AM IST
- The colour purple that has left drug makers like Dr Reddy's Laboratories paleThe reference here has nothing to do with the Pulitzer-winning book of Alice Walker, but the actual colour that has pushed big pharma to pu...14 Nov, 2015, 02.53 PM IST
- AstraZeneca Pharma shares end 14% higher post earningsShares of AstraZeneca Pharma India today soared 14 per cent after the company reported a net profit of Rs 38.12 crore for the fourth quarte...28 May, 2015, 06.47 PM IST
- AstraZeneca Pharma Q4 net profit at Rs 38 croreNet sales stood at Rs 120.80 crore during the quarter, while the same were at Rs 114.14 crore during the same period in the previous fiscal.27 May, 2015, 06.24 PM IST
- Earnings, ANDA approvals to supplement pharma stocks: Neeraj Deewan, Quantum SecuritiesA continuous improvement in earnings on sequential basis will continue and pharma stocks may keep on performing well, believes Quantum Secu...05 Mar, 2015, 04.24 PM IST
- Connecticut AG George Jepsen to USFDA: Pull up Ranbaxy for failing to launch drug NexiumRanbaxy was scheduled to launch the generic version of drug Nexium in US under a 6-month exclusive marketing opportunity, but it failed to ...13 Sep, 2014, 04.00 AM IST
- AstraZeneca Pharma rallies nearly 13% on strong Q3 showAstraZeneca Pharma rallied as much as 12.5% after the Pharma major posted a net profit of Rs 1.51 cr for the third quarter ended Dec 31, 20...11 Feb, 2014, 10.24 AM IST
- Astrazeneca Pharma Q3 net loss at Rs 18 croreAstrazeneca Pharma today posted a net loss of Rs 17.69 crore for its third quarter ended December 31, 2012.06 Feb, 2013, 07.36 PM IST
- AstraZeneca Q4 net loss at Rs 33 crAstraZeneca Pharma India today reported a net loss of Rs 33 crore for the quarter ended March 31, 2012, due to a voluntary recall of steril...12 May, 2012, 04.40 PM IST
- Ranbaxy Laboratories to supply low-cost version of Nexium by 2011-endAstraZeneca is awaiting approval from USFDA but we expect to start shipping the product in the second half of this year.12 May, 2011, 06.56 AM IST
- AstraZeneca Dec qtr net up 28.26% at Rs 28.32 crAstraZeneca Pharma India on Tuesday said its net profit rose by 28.26% to Rs 28.32 crore for the quarter ended December 31,2010.08 Feb, 2011, 08.05 PM IST
- Astrazeneca Pharma June qtr net down 52 pc at Rs 7.3 crDrug maker Astrazeneca Pharma on Tuesday posted a 52.1 per cent decline in its net profit at Rs 7.31 crore in the quarter ended June 30, 20...27 Jul, 2010, 10.27 PM IST
Load More
